| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,414 |
2,403 |
$153K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,681 |
3,093 |
$141K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,554 |
2,942 |
$101K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,391 |
1,387 |
$61K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,143 |
2,712 |
$52K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
100 |
99 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
210 |
206 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
81 |
74 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
98 |
97 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
46 |
41 |
$1K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
19 |
12 |
$713.15 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
422 |
200 |
$367.20 |
| 99051 |
|
48 |
45 |
$325.22 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
74 |
72 |
$285.94 |
| 0012A |
|
17 |
15 |
$228.38 |
| 0011A |
|
39 |
39 |
$132.56 |
| 96127 |
|
204 |
193 |
$131.27 |
| 99072 |
|
918 |
829 |
$105.00 |
| 1111F |
|
729 |
635 |
$75.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
534 |
497 |
$55.46 |
| 36415 |
Collection of venous blood by venipuncture |
971 |
938 |
$26.69 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
350 |
323 |
$0.00 |
| 1126F |
|
40 |
39 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
495 |
452 |
$0.00 |
| 99000 |
|
509 |
475 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
79 |
71 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
72 |
66 |
$0.00 |
| 1036F |
|
60 |
52 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
28 |
28 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
339 |
289 |
$0.00 |
| 99080 |
|
1,163 |
279 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
118 |
99 |
$0.00 |
| 1159F |
|
77 |
71 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
222 |
204 |
$0.00 |
| 81002 |
|
17 |
17 |
$0.00 |
| 96160 |
|
23 |
18 |
$0.00 |
| 1160F |
|
76 |
70 |
$0.00 |
| 1124F |
|
14 |
14 |
$0.00 |
| 99408 |
|
17 |
14 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
17 |
16 |
$0.00 |